UEC Stock Analysis: Uranium Energy | NYSE MKT
Uranium | NYSE MKT, USA | Market Cap: 6.255m USD | 12M Return: 31.3% | US9168961038 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 85.9M
Qual. Beats: -5
Rev. Trend: -13.5%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Uranium Energy Corp. (UEC) is a U.S.-headquartered mining company that operates across the full uranium value chain-including exploration, pre-extraction, extraction, and processing-primarily producing uranium and titanium concentrates. The companys operations span three jurisdictions: the United States, Canada, and Paraguay, giving it a geographically diversified asset base for uranium development.
The company is incorporated in 2003 and was originally known as Carlin Gold Inc. before rebranding to its current name in January 2005. It is headquartered in Corpus Christi, Texas, a region historically associated with U.S. uranium production. Listed on the NYSE MKT under the ticker UEC since its 2007 IPO, the company is classified within the Energy sector under the GICS framework.
Uranium miners such as UEC supply feedstock for the global nuclear power industry, positioning them as upstream participants in the nuclear fuel cycle. The companys inclusion of titanium concentrates alongside uranium reflects a secondary commodity exposure, while its multi-country footprint provides jurisdictional optionality in a sector where permitting, regulation, and resource nationalism can materially affect project economics.
- Uranium spot prices rally on supply constraints and reactor demand
- UEC expands production capacity through acquisitions of uranium assets
- US ban on Russian uranium imports supports domestic producer margins
| Net Income: -103.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.08 > 0.02 and ΔFCF/TA -1.95 > 1.0 |
| NWC/Revenue: 2.79k% < 20% (prev 205.8%; Δ 2.59k% < -1%) |
| CFO/TA -0.07 > 3% & CFO -113.5m > Net Income -103.7m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 32.67 > 1.5 & < 3 |
| Outstanding Shares: last quarter (490.7m) vs 12m ago 14.13% < -2% |
| Gross Margin: 26.28% > 18% (prev 8.44%; Δ 17.84% > 0.5%) |
| Asset Turnover: 1.59% > 50% (prev 6.63%; Δ -5.05% > 0%) |
| Interest Coverage Ratio: -60.45 > 6 (EBIT TTM -123.1m / Interest Expense TTM 2.04m) |
| A: 0.37 (Total Current Assets 581.6m - Total Current Liabilities 17.8m) / Total Assets 1.54b |
| B: -0.31 (Retained Earnings -483.2m / Total Assets 1.54b) |
| C: -0.10 (EBIT TTM -123.1m / Avg Total Assets 1.27b) |
| D: 12.19 (Book Value of Equity 1.42b / Total Liabilities 116.6m) |
| Altman-Z'' = 13.53 = AAA |
| DSRI: 3.0 (Receivables 7.13m/4.91m, Revenue 20.2m/66.8m) |
| GMI: 0.32 (GM 8.44% / 26.28%) |
| AQI: 7.51 (AQ_t 0.58 / AQ_t-1 0.08) |
| SGI: 0.30 (Revenue 20.2m / 66.8m) |
| TATA: 0.01 (NI -103.7m - CFO -113.5m) / TA 1.54b) |
| Beneish M = 1.37 (Cap -4..+1) = D |
As of August 28, 2026, the stock is trading at USD 13.62 with a total of 8,708,700 shares traded. Over the past week, the price has changed by +22.15%, over one month by +37.44%, over three months by +1.34% and over the past year by +31.34%.
Current recommended Stop Loss: 12.70 (which is 6.8% or 1.3 ATR below the current price).
Uranium Energy has received a consensus analysts rating of 4.38. Therefore, it is recommended to buy UEC.
- StrongBuy: 3
- Buy: 5
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 18 | 32.4% |
P/E Forward = 178.5714
P/S = 303.5971
P/B = 4.4422
P/EG = 1.3733
Revenue TTM = 20.2m USD
EBIT TTM = -123.1m USD
EBITDA TTM = -116.7m USD
Long Term Debt = 1.22m USD (estimated: total debt 1.91m - short term 693k)
Short Term Debt = 693k USD (from shortTermDebt, last quarter)
Debt = 3.25m USD (from shortLongTermDebtTotal, last quarter) + Leases 1.34m
Net Debt = -484.8m USD (calculated: Debt 3.25m - CCE 488.1m)
Enterprise Value = 5.77b USD (6.26b + Debt 3.25m - CCE 488.1m)
Interest Coverage Ratio = -60.45 (Ebit TTM -123.1m / Interest Expense TTM 2.04m)
EV/FCF = -47.99x (Enterprise Value 5.77b / FCF TTM -120.2m)
FCF Yield = -2.08% (FCF TTM -120.2m / Enterprise Value 5.77b)
FCF Margin = -595.2% (FCF TTM -120.2m / Revenue TTM 20.2m)
Net Margin = -513.2% (Net Income TTM -103.7m / Revenue TTM 20.2m)
Gross Margin = 26.28% ((Revenue TTM 20.2m - Cost of Revenue TTM 14.9m) / Revenue TTM)
Gross Margin QoQ = none% (prev 49.64%)
Tobins Q-Ratio = 3.75 (Enterprise Value 5.77b / Total Assets 1.54b)
Interest Expense / Debt = 62.66% (Interest Expense 2.04m / Debt 3.25m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -97.3m (EBIT -123.1m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 32.67 (Total Current Assets 581.6m / Total Current Liabilities 17.8m)
Debt / Equity = 0.00 (Debt 3.25m / totalStockholderEquity, last quarter 1.42b)
Debt / EBITDA = 4.15 (negative EBITDA) (Net Debt -484.8m / EBITDA -116.7m)
Debt / FCF = 4.03 (negative FCF - burning cash) (Net Debt -484.8m / FCF TTM -120.2m)
Total Stockholder Equity = 1.28b (last 4 quarters mean from totalStockholderEquity)
RoA = -8.14% (Net Income -103.7m / Total Assets 1.54b)
RoE = -8.08% (Net Income TTM -103.7m / Total Stockholder Equity 1.28b)
RoCE = -9.59% (EBIT -123.1m / Capital Employed (Equity 1.28b + L.T.Debt 1.22m))
RoIC = -6.40% (negative operating profit) (NOPAT -97.3m / Invested Capital 1.52b)
WACC = 14.15% (E(6.26b)/V(6.26b) * Re(14.16%) + (debt cost/tax rate unavailable))
Discount Rate = 14.16% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 95.87 | Cagr: 9.12%
[DCF] Fair Price = unknown (Cash Flow -120.2m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -4.0 | # QB: -5
Revenue Correlation: -13.49 | Revenue CAGR: -22.47% | SUE: -0.23 | # QB: 0
EPS current Quarter (2026-10-31): EPS=0.00 | Chg30d=N/A | Revisions=+0% | Analysts=1
EPS current Year (2026-07-31): EPS=-0.18 | Chg30d=+1.82% | Revisions=-40% | GrowthEPS=-9.3% | GrowthRev=-62.4%
EPS next Year (2027-07-31): EPS=-0.09 | Chg30d=+15.65% | Revisions=-40% | GrowthEPS=+50.9% | GrowthRev=+397.7%
[Analyst] Revisions Ratio: -57% (up=0, down=4)